---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-052469"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:39:15.087823+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Onconetix CFO Bruce Harmon resigns; Karina Fedasz appointed interim CFO

## Summary
- Bruce Harmon resigned as CFO effective June 8, 2024; receives $66,152.61 severance under release agreement.
- Karina M. Fedasz, 51, appointed Interim CFO effective June 10, 2024; CFO Squad LLC engaged for accounting services.
- Fedasz previously served as CFO at IDW Media Holdings and Head of Business Development at Evofem Biosciences.
- Compensation for Fedasz to be determined later; Harmon's unvested equity forfeited.

## SEC filing metadata
- accession: 0001213900-24-052469
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390024052469/0001213900-24-052469-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390024052469/ea0207635-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-052469
- JSON: https://secwatch.observer/filing/0001213900-24-052469.json
- Plain text: https://secwatch.observer/filing/0001213900-24-052469.txt

## Key facts
- Executive change
  Karina M. Fedasz was appointed as Interim Chief Financial Officer at Onconetix, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: On June 10, 2024, the Company appointed Karina M. Fedasz, 51, as Interim Chief Financial Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390024052469/0001213900-24-052469-index.htm
- Executive change
  Bruce Harmon resigned as Chief Financial Officer at Onconetix, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On June 8, 2024, Bruce Harmon resigned as Chief Financial Officer of Onconetix, Inc. (the “ Company ”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390024052469/0001213900-24-052469-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.